Back to results
US 2006/0040951 A1Published application
Use of 5-ht2 receptor antagonists for the treatment of sleep disorders
AssigneeMerck Patent GmbH
InventorsGerd Bartoszyk, Christoph Van Amsterdam
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of 5-HT2 receptor antagonists for the preparation of a medicament for extending both non-REM sleep an REM sleep.
Claims6
Use of 5-HT2 receptor antagonists and physiologically acceptable salts and solvates thereof for the preparation of a medicament for extending both non-REM sleep and REM sleep.
Use of (3-cyano-1H-indol-7-yl)-[4-(4- fluorophenethyl)piperazin-1-yl]methanone and physiologically acceptable salts and solvates thereof for the preparation of a medicament for extending both non-REM sleep and REM sleep.
Dependencies are inferred from the claim text.